Dishman Carbogen Amcis Ltd — Quarterly Results & Earnings

₹129.97

-7.38%

Profit Growth YoY88.81%Latest quarter

Sales Growth YoY-17.29%Latest quarter

Sales CAGR 5Y5.82%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+88.81%

🔥 Exceptional growth

YoY Sales Growth-17.29%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

14.36%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

1.77

ROE

-0.32%

ROCE

2.42%

💡

Growth Analysis

Dishman Carbogen Amcis Ltd reported YoY profit growth of 88.81% and revenue growth of -17.29% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.82% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Dishman Carbogen Amcis Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.